# FDA Inspection 1211387 - Philip R. Clingan - July 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/philip-r-clingan/28c53fa1-4013-46d7-b21d-7ffb3a4c12e3
Source feed: FDA_Inspections

> FDA Inspection 1211387 for Philip R. Clingan on July 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211387
- Company Name: Philip R. Clingan
- Inspection Date: 2023-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/philip-r-clingan/615c0605-a042-4731-803a-5655a9d890bc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c